This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Rodney Simon Kittlety: Innovator in Peptide Release Technology
Introduction
Rodney Simon Kittlety is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of peptide release technology. His innovative approach has the potential to enhance quality control processes in drug development.
Latest Patents
Kittlety holds a patent for a method titled "Method for determining release of a peptide from a sustained release polylactide formulation." This method allows for the determination of peptide release in a shorter time frame compared to traditional real-time methods. By accelerating the release of the peptide from the formulation, this technique can effectively discriminate between different batches for quality control purposes, as well as differentiate formulations with varying drug loadings.
Career Highlights
Rodney Kittlety is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in drug formulation and delivery.
Collaborations
Kittlety has collaborated with esteemed colleagues such as Brian Collingwood Clark and David Michael Cross. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Rodney Simon Kittlety's contributions to peptide release technology exemplify the impact of innovation in the pharmaceutical industry. His work not only enhances quality control but also paves the way for improved drug formulations.